msforumonline.net

issue 2 volume 12 2005

ISSN 1352-8963 (print) || ISSN 1469-3410 (online)
• Licensing and Use of New Therapies in MS: Where Are We Going?
   B Hurwitz
• Neurodegeneration and Clinical Relevance for Early Treatment in Multiple Sclerosis
   P Rieckmann
• Cyclophosphamide Therapy for MS
   SA Gauthier, HL Weiner
• Managing Specific Symptoms in People with Multiple Sclerosis
   T Henze
• Progressive multifocal leukoencephalopathy in a patient treated with natalizumab
   A Langer-Gould
• Stabilization of rapidly worsening MS for 36 months in patients treated with interferon beta plus cyclophosphamide followed by interferon beta
   F Patti
• Progressive multifocal leukoencephalopathy after natalizumab therapy for crohns disease
   G Van Assche
• Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis
   BK Kleinschmidt-DeMasters
• Therapeutic Developments in MS: Report from the 57th Annual Meeting of the American Academy of Neurology (AAN), 9-15 April 2004, Miami, Florida, USA
   M Clanet